对虾转基因研究的现状和展望

随着生物技术的发展,通过基因工程手段获得对虾新品种成为可能,然而经过十几年努力,目前对虾转基因研究依然处于初级阶段。各国科学家正在加紧研究,争取有所突破。综述了近年来国内外对虾转基因研究的进展以及目前面临的技术和安全问题,同时对未来对虾的转基因技术发展和应用前景进行了讨论 。     

Strategies for Analysis of the Glycosylation of Proteins: Current Status and Future Perspectives

More than half of human proteins are glycosylated by a bewildering array of complex and heterogeneous N- and O-linked glycans. They function in myriad biological processes, including cell adhesion and signalling and influence the physical characteristics, stability, function, activity and immunogenicity of soluble glycoproteins. A single protein may be glycosylated differently to yield heterogenous glycoforms. Glycosylation analysis is of increasing interest in biomedical and biological research, the pharmaceutical and healthcare industry and biotechnology. This is because it is increasingly apparent that glycosylation changes in diseases, such as cancer, making it a promising target for development of clinically useful biomarkers and therapeutics. Furthermore, as the non-human cells employed in expression systems glycosylate their proteins very differently to human cells, and as glycosylation changes unpredictably under changing environmental conditions, glycans analysis for quality control, optimum efficacy and safety of recombinant glycoproteins destined for human therapeutic use is paramount. The complexities of carbohydrate chemistry make analysis challenging and while there are a variety of robust methodologies available for glycan analysis, there is currently a pressing need for the development of new, streamlined, high throughput approaches accessible to non-specialist laboratories.     

Thermophilic Hydrogen Production from Renewable Resources: Current Status and Future Perspectives

Hydrogen (H₂) is considered an alternative fuel of the future due to its high energy density and non-polluting nature. H₂ energy provides many advantages over fossil fuels in that it is renewable, eco-friendly, and efficient. The global demand for H₂ is increasing significantly; however, matching the supply of cost-competitive H₂ to meet the current demand is a major technological barrier. H₂ can be produced from lignocellulosic biomass and serve as a raw material for the synthesis of many industrially important chemicals. The use of thermophilic bacteria for biological production of H₂ appears to be a promising alternative route to the current H₂ production technologies. However, the carbon and H₂ production metabolisms in most thermophilic bacteria have not yet been completely understood. This paper summarizes the recent research progress made toward understanding the carbon utilization for H₂ production and developing gene manipulation techniques to enhance the H₂ production capabilities in thermophilic bacteria. It reviews the current status, future directions and opportunities that thermophiles can offer to enable a cost-competitive and environmentally benign H₂ production bioprocess.     

核酸生物传感器及其研究进展

核酸生物传感器在涉及分子生物学的研究领域具有重要意义.为适应分子生物学及其相关学科的发展需要,其研究正成为90年代生物传感技术研究热点.文章对核酸生物传感器的工作原理、分类、研究现状以及发展趋势作了较详细的介绍.     

Current and Future Transgenic Whole-Cell Biosensors for Plant Macro- and Micronutrients

From the soil, plants take up macronutrients (calcium, magnesium, nitrogen, phosphorus, potassium, sulfur) and micronutrients (boron, chloride, cobalt, copper, iron, manganese, molybdenum, nickel, selenium, and zinc). In acidic soils, aluminum can interfere with nutrient uptake. There is a need for improved diagnostic tests for these soil-derived minerals that are inexpensive and sensitive, provide spatial and temporal information in plants and soil, and report bioavailable nutrient pools. A transgenic whole-cell biosensor detects a stimulus inside or outside a cell and causes a change in expression of a visible reporter such as green fluorescent protein, and thus can convert an invisible plant nutrient into a visible signal. Common transgenic whole-cell biosensors consist of promoter-reporter fusions, auxotrophs for target analytes that are transformed with constitutively expressed reporters, riboswitches and reporters based on Forster Resonance Energy Transfer (FRET). Here, we review transgenic plant biosensors that have been used to detect macronutrients and micronutrients. As plant-based biosensors are limited by the requirement to introduce and optimize a transgene in every genotype of interest, we also review microbial biosensor cells that have been used to measure plant or soil nutrients by co-inoculation with their respective extracts. Additionally, we review published transgenic whole-cell biosensors from other disciplines that have the potential to measure plant nutrients, with the goal of stimulating the development of these diagnostic technologies. We discuss current limitations and future improvements needed, and the long-term potential of transgenic whole-cell biosensors to inform plant physiology, improve soil nutrient management, and assist in breeding crops with improved nutrient use efficiency.     

Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives

Pharmacological and genetic tools targeting the 5-hydroxytryptamine (5-HT)7 receptor in preclinical animal models have implicated this receptor in diverse (patho)physiological processes of the central nervous system (CNS). Some data obtained with 5-HT7 receptor knockout mice, selective antagonists, and, to a lesser extent, agonists, however, are quite contradictory. In this review, we not only discuss in detail the role of the 5-HT7 receptor in the CNS but also propose some hypothetical models, which could explain the observed inconsistencies. These models are based on two novel concepts within the field of G protein-coupled receptors (GPCR), namely biphasic signaling and G protein-independent signaling, which both have been shown to be mediated by GPCR dimerization. This led us to suggest that the 5-HT7 receptor could reside in different dimeric contexts and initiate different signaling pathways, depending on the neuronal circuitry and/or brain region. In conclusion, we highlight GPCR dimerization and G protein-independent signaling as two promising future directions in 5-HT7 receptor research, which ultimately might lead to the development of more efficient dimer- and/or pathway-specific therapeutics.     

纳米抗体技术及其在疾病诊断和治疗中的应用

单克隆抗体具有特异性结合抗原的能力,已被广泛应用于疾病诊断及治疗领域.但因单克隆抗体的组织渗透能力较差、体内的保留时间较长以及制备过程繁琐,从而限制了其在临床中的应用.自1993年首次报道在骆驼体内天然存在的单链抗体(HCAb)以来,由于其可变区间VHH(纳米抗体)具有体积小、溶解度高、特异性强以及可在细菌中大量表达等优点,较之传统单克隆抗体,VHH在疾病的诊断治疗及药物开发等医学领域具有更广阔的应用前景.本文综述了:纳米抗体的骨架区及互补决定区与传统抗体重链相应区间的结构比较;纳米抗体库的构建以及运用噬菌体展示技术对VHH库的筛选;纳米抗体技术在疾病诊断中的应用及其用于分子显像的优势,以及纳米抗体作为抗肿瘤免疫偶联物的靶向组分在癌症治疗领域中的最新进展.     

The Multifaceted Role of Long Non-Coding RNA in Gastric Cancer: Current Status and Future Perspectives

Gastric cancer (GC) is one of the major public health concerns. Long non-coding RNAs (lncRNAs) have been increasingly demonstrated to possess a strong correlation with GC and play a critical role in GC occurrence, progression, metastasis and drug resistance. Many studies have shed light on the understanding of the underlying mechanisms of lncRNAs in GC. In this review, we summarized the updated research about lncRNAs in GC, focusing on their roles in Helicobacter pylori infection, GC metastasis, tumor microenvironment regulation, drug resistance and associated signaling pathways. LncRNAs may serve as novel biomarkers for diagnosis and prognosis of GC and potential therapeutic targets. The research gaps and future directions were also discussed.     

Fish Gut Microbiome: Current Approaches and Future Perspectives

In recent years, investigations of microbial flora associated with fish gut have deepened our knowledge of the complex interactions occurring between microbes and host fish. The gut microbiome not only reinforces the digestive and immune systems in fish but is itself shaped by several host-associated factors. Unfortunately, in the past, majority of studies have focused upon the structure of fish gut microbiome providing little knowledge of effects of these factors distinctively and the immense functional potential of the gut microbiome. In this review, we have highlighted the recently gained insights into the diversity and functions of the fish gut microbiome. We have also delved on the current approaches that are being employed to study the fish gut microbiome with an aim to collate all the knowledge gained and make accurate conclusions for their application based perspectives. The literature reviewed indicated that the future research should shift towards functional microbiomics to improve the maximum sustainable yield in aquaculture.     

Pichia pastoris as a Versatile Cell Factory for the Production of Industrial Enzymes and Chemicals: Current Status and Future Perspectives

With nearly three decades of development, Pichia pastoris (P. pastoris) has become a powerful eukaryotic protein expression system for the expression of thousands of proteins both on a laboratory and industrial scale. In addition, it has also been extensively used as a cell factory for the production of a variety of chemicals. This review summarizes the bottlenecks and solutions in achieving high‐level secretory protein expression with P. pastoris and then outlines its applications on chemical production with an emphasis on its role as whole‐cell biocatalyst. Furthermore, current challenges and future directions of this important system are also discussed.     

Glutamate Signaling in Benign and Malignant Disorders: Current Status,Future Perspectives,and Therapeutic Implications

Glutamate, a nonessential amino acid, is the major excitatory neurotransmitter in the central nervous system. As such, glutamate has been shown to play a role in not only neural processes, such as learning and memory, but also in bioenergetics, biosynthetic and metabolic oncogenic pathways. Glutamate has been the target of intense investigation for its involvement not only in the pathogenesis of benign neurodegenerative diseases (NDDs) such as Parkinson''s disease, Alzheimer''s disease, schizophrenia, multiple sclerosis, and amyotropic lateral sclerosis (ALS), but also in carcinogenesis and progression of malignant diseases. In addition to its intracellular activities, glutamate in secreted form is a phylogenetically conserved cell signaling molecule. Glutamate binding activates multiple major receptor families including the metabotropic glutamate receptors (mGluRs) and ionotropic glutamate receptors (iGluRs), both of which have been implicated in various signaling pathways in cancer. Inhibition of extracellular glutamate release or glutamate receptor activation via competitive or non-competitive antagonists decreases growth, migration and invasion and induces apoptosis in breast cancer, melanoma, glioma and prostate cancer cells. In this review, we discuss the current state of glutamate signaling research as it relates to benign and malignant diseases. In addition, we provide a synopsis of clinical trials using glutamate antagonists for the treatment of NDD and malignant diseases. We conclude that in addition to its potential role as a metabolic biomarker, glutamate receptors and glutamate-initiated signaling pathways may provide novel therapeutic opportunities for cancer.     

抗菌肽的研究现状和挑战

抗菌肽(AMPs)广泛存在于生物体内,可以协助机体抵御外源微生物的侵害,是生物体先天性防御系统中的重要组成成分。普遍认为,抗菌肽通过膜损伤机制,破坏微生物细胞膜或细胞壁的完整性,达到抑杀微生物的目的。然而,越来越多的证据表明抗菌肽还存在非膜损伤机制,作用于胞内靶位点杀伤细胞。由于其独特的作用机制及广谱抗菌活性,抗菌肽被应用于各行各业。但是,抗菌肽的推广应用也面临着诸多难题,如生物稳定性、抗菌活性的维持和微生物耐受性等。主要对抗菌肽的种类、作用机制、微生物对抗菌肽耐受性的产生机制及抗菌肽的应用和挑战进行综述。     

Clinical Use of Aromatase Inhibitors: Current Data and Future Perspectives

Abstract

A systematic procedure for the kinetic study of irreversible inhibition when the enzyme is consumed in the reaction which it catalyses, has been developed and analysed. Whereas in most reactions the enzymes are regenerated after each catalytic event and serve as reusable transacting effectors, in the consumed enzymes each catalytic center participates only once and there is no enzyme turnover. A systematic kinetic analysis of irreversible inhibition of these enzyme reactions is presented. Based on the algebraic criteria proposed in this work, it should be possible to evaluate either the mechanism of inhibition (complexing or non-complexing), or the type of inhibition (competitive, non-competitive, uncompetitive, mixed non-competitive). In addition, all kinetic constants involved in each case could be calculated. An experimental application of this analysis is also presented, concerning peptide bond formation in vitro. Using the puromycin reaction, which is a model reaction for the study of peptide bond formation in vitro and which follows the same kinetic law as the enzymes under study, we have found that: (i) the antibiotic spiramycin inhibits the puromycin reaction as a competitive irreversible inhibitor in a one step mechanism with an association rate constant equal to 1.3 × 10⁴M^-1s^-1 and, (ii) hydroxylamine inhibits the same reaction as an irreversible non-competitive inhibitor also in a one step mechanism with a rate constant equal to 1.6 × 10^-3 M^-1s^-1.     

转移性结直肠癌抗血管生成靶向治疗的研究进展

近年来,由于各种新的化疗药物及分子靶向药物的使用,转移性结直肠癌(metastatic colorectal cancer,m CRC)的个体化治疗逐步取得了重要的成果。研究表明,抗血管生成靶向药物与化疗药物的联合使用作为转移性结直肠癌的一线治疗方案,可明显改善治疗效果,延长患者的生存时间。血管内皮生长因子(vascularendothelial growth factor,VEGF)是肿瘤血管生成过程中最主要的因子。贝伐单抗是通过基因工程技术得到的针对血管内皮生长因子-A(VEGF-A)的单克隆抗体,作为抗血管生成靶向药物用于转移性结直肠癌的临床治疗。本文对近年来转移性结直肠癌的抗血管生成靶向治疗,尤其是贝伐单抗治疗的相关研究进展进行综述并展望未来抗血管生成靶向治疗的发展前景。